Missing data were not imputed
Both work by gently encouraging your body to release more of its own growth hormone rather than introducing synthetic growth hormone from outside
F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B
IGF-1 LR3 Potency and Pharmacological Profile Research has demonstrated that both IGF-1 and IGF-1 LR3 exhibit robust bioactivity at the IGF-1 receptor, with IGF-1 LR3 showing superior cell proliferation effects attributable to its reduced IGFBP sequestration with the study concluding that IGF-1 LR3 holds considerable promise for scientific applications, particularly due to its prolonged receptor availability
The No DAC (Drug Affinity Complex) version is specifically chosen for its shorter half-life, more closely mimicking the natural physiological spikes of human GH
For personalized advice, see a nutritionist or an endocrinologist